Valentin Fulga

Amministratore Delegato presso Theravitae Co. Ltd.

Health Technology

Consumer Services

Posizioni attive di Valentin Fulga

Società	Posizione	Inizio	Fine
Theravitae Co. Ltd. Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Theravitae Co. Ltd. offers stem cell therapies for cardiac patients. Its product includes VesCell that is used in curing coronary heart disease, congestive heart failure and cardiomyopathy. The company was founded by Robert Clark and Valentin Fulga in 2003 and is headquartered in Bangkok, Thailand.	Amministratore Delegato	01/01/2003	-
	Fondatore	04/03/2011	-

Società	Posizione	Inizio	Fine
W WORL	Corporate Officer/Principal	-	-
HEMOSTEMIX INC.	Direttore/Membro del Consiglio	-	-
TheraVitae, Inc. TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada.	Amministratore Delegato	-	-
	Presidente	-	-
	Presidente	-	-

Ben-Gurion University of the Negev

Undergraduate Degree

Distribuzione geografica

Posizioni

Settori

Health Technology	5
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
W WORL	Health Technology
HEMOSTEMIX INC.	Health Technology

Aziende private	2
TheraVitae, Inc. TheraVitae, Inc. BiotechnologyHealth Technology TheraVitae, Inc. developed and commercialized adult stem cell technologies. Its products were used to treat cardiovascular diseases. The company was headquartered in Toronto, Canada.	Health Technology
Theravitae Co. Ltd. Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Theravitae Co. Ltd. offers stem cell therapies for cardiac patients. Its product includes VesCell that is used in curing coronary heart disease, congestive heart failure and cardiomyopathy. The company was founded by Robert Clark and Valentin Fulga in 2003 and is headquartered in Bangkok, Thailand.	Health Technology